Aliases & Classifications for Uveal Diseases

Aliases & Descriptions for Uveal Diseases:

Name: Uveal Diseases 50 69

Classifications:



Summaries for Uveal Diseases

MalaCards based summary : Uveal Diseases is related to diphtheria and uveitis, and has symptoms including eye manifestations and mydriasis. The drugs Heparin and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include eye.

Related Diseases for Uveal Diseases

Diseases related to Uveal Diseases via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 diphtheria 9.6
2 uveitis 9.6
3 retinitis 9.6

Symptoms & Phenotypes for Uveal Diseases

UMLS symptoms related to Uveal Diseases:


eye manifestations, mydriasis

Drugs & Therapeutics for Uveal Diseases

Drugs for Uveal Diseases (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 352)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Heparin Approved, Investigational Phase 4,Phase 2 9005-49-6 772 46507594
2
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-02-2 5743
3
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
4
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
5
Mycophenolic acid Approved Phase 4,Phase 3 24280-93-1 446541
6
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3 128794-94-5 5281078
7
Ganciclovir Approved, Investigational Phase 4 82410-32-0 3454
8
Azathioprine Approved Phase 4,Phase 2 446-86-6 2265
9
Infliximab Approved Phase 4,Phase 3,Phase 1,Phase 2 170277-31-3
10
Timolol Approved Phase 4,Phase 3 26839-75-8 33624 5478
11
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
12
Verteporfin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 129497-78-5
13
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 124-94-7 31307
14
Latanoprost Approved, Investigational Phase 4 130209-82-4 5282380 5311221
15
Ranibizumab Approved Phase 4,Phase 3,Phase 2,Phase 1 347396-82-1 459903
16
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
17
Fluocinolone Acetonide Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 67-73-2 6215
18
Bevacizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 216974-75-3
19
Travoprost Approved Phase 4,Phase 3 157283-68-6 5282226
20
Povidone-iodine Approved Phase 4,Phase 3 25655-41-8
21
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
22
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
23
Chlorambucil Approved Phase 4 305-03-3 2708
24
Tamsulosin Approved, Investigational Phase 4 106133-20-4 129211
25
Ephedrine Approved Phase 4,Phase 3,Phase 1,Phase 2 299-42-3 9294
26
Tobramycin Approved, Investigational Phase 4 32986-56-4 5496 36294
27
Dorzolamide Approved Phase 4 120279-96-1 3154 5284549
28
Daclizumab Approved, Investigational Phase 4,Phase 2,Phase 1 152923-56-3
29
Pseudoephedrine Approved Phase 4,Phase 3,Phase 1,Phase 2 90-82-4 7028
30
Alfuzosin Approved, Investigational Phase 4 81403-80-7 2092
31
Bimatoprost Approved, Investigational Phase 4 155206-00-1 5311027
32
Difluprednate Approved Phase 4,Phase 3,Phase 2 23674-86-4 443936
33
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2 53-03-2 5865
34
Ofloxacin Approved Phase 4 82419-36-1 4583
35
Certolizumab pegol Approved Phase 4 428863-50-7
36
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
37
Nepafenac Approved Phase 4 78281-72-8 151075
38
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1 58-05-9 54575, 6560146 143
39
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 59-30-3 6037
40
Bromfenac Approved July 1997 Phase 4 91714-94-2 60726
41
Maleic acid Experimental Phase 4,Phase 2 110-16-7 444266
42
Iodine Phase 4,Phase 2,Phase 1 7553-56-2 807
43 triamcinolone acetonide Phase 4,Phase 2,Phase 3,Phase 1
44 cadexomer iodine Phase 4,Phase 2,Phase 1
45 calcium heparin Phase 4,Phase 2
46 Prednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1
47 Dexamethasone acetate Phase 4,Phase 3,Phase 2,Phase 1 1177-87-3
48 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
49 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1
50 glucocorticoids Phase 4,Phase 2,Phase 3,Phase 1

Interventional clinical trials:

(show top 50) (show all 610)
id Name Status NCT ID Phase
1 Evaluating Results of Neusidl Corneal Inserter in Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) Unknown status NCT01357122 Phase 4
2 Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization Unknown status NCT02033018 Phase 4
3 Ranibizumab for Myopic Neovascularization Unknown status NCT01246089 Phase 4
4 Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease Unknown status NCT00720928 Phase 4
5 The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease Unknown status NCT01306955 Phase 4
6 Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) Unknown status NCT02092532 Phase 4
7 Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis Unknown status NCT01669447 Phase 4
8 Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy Unknown status NCT00540930 Phase 4
9 Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis Completed NCT00589628 Phase 4
10 Corneal Specular Microscopy in Infectious and Noninfectious Uveitis Completed NCT00789984 Phase 4
11 Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment Completed NCT00543296 Phase 4
12 Multicenter Uveitis Steroid Treatment (MUST) Trial Completed NCT00132691 Phase 4
13 Assessing Cosopt Switch Patients Completed NCT00273442 Phase 4
14 Aqueous Flare of a Hydrophobic Acrylic Single-piece Open-loop IOL With Modified Material Surface Properties Completed NCT01767012 Phase 4
15 A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery Completed NCT00170729 Phase 4
16 The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil Completed NCT03144596 Phase 4
17 Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab Completed NCT00417703 Phase 4
18 Bevacizumab Intravitreal for Myopic Choroidal Neovascularization Completed NCT00797992 Phase 4
19 Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG Completed NCT01978015 Phase 4
20 Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery Completed NCT02137161 Phase 4
21 TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema Completed NCT01870440 Phase 4
22 Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients Completed NCT02764697 Phase 4
23 Photodynamic Therapy in Occult-Only Lesions (POOL) Completed NCT00135837 Phase 4
24 Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT) Completed NCT01006538 Phase 4
25 Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD) Completed NCT01148511 Phase 4
26 Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration. Completed NCT01831947 Phase 4
27 Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab Completed NCT01810042 Phase 4
28 Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization Completed NCT00645697 Phase 4
29 Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration Completed NCT01628354 Phase 4
30 Evaluation of Dosing Interval of Higher Doses of Ranibizumab Completed NCT00533520 Phase 4
31 Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration Completed NCT00473642 Phase 4
32 PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization Completed NCT00358345 Phase 4
33 Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration Completed NCT00504959 Phase 4
34 Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy Recruiting NCT02735213 Phase 4
35 Study of the Effectiveness of Ozurdex for the Control of Uveitis Recruiting NCT02049476 Phase 4
36 Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization Recruiting NCT03042871 Phase 4
37 Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3) Recruiting NCT02320474 Phase 4
38 PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial Recruiting NCT02374060 Phase 4
39 A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU Recruiting NCT03020992 Phase 4
40 Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis Recruiting NCT02943057 Phase 4
41 Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Primarily Intra-retinal Fluid) Treatment. Active, not recruiting NCT01972789 Phase 4
42 TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy Active, not recruiting NCT02379000 Phase 4
43 Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis Not yet recruiting NCT02769702 Phase 4
44 Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis Not yet recruiting NCT03066869 Phase 4
45 Topical Treatment for Uveitic Macular Edema Not yet recruiting NCT01939691 Phase 4
46 Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema Not yet recruiting NCT02598869 Phase 4
47 Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation Not yet recruiting NCT03133767 Phase 4
48 Clincial Safety and Efficacy of Hydrophilic Acrylic Intraocular Lenses Not yet recruiting NCT03145116 Phase 4
49 Clinical Safety and Efficacy of Hydrophilic Acrylic Intraocular Lenses Not yet recruiting NCT03145103 Phase 4
50 Use of Thalidomide in Chronic Uveitis Terminated NCT00314665 Phase 4

Search NIH Clinical Center for Uveal Diseases

Genetic Tests for Uveal Diseases

Anatomical Context for Uveal Diseases

MalaCards organs/tissues related to Uveal Diseases:

39
Eye

Publications for Uveal Diseases

Articles related to Uveal Diseases:

id Title Authors Year
1
Golden retriever cystic uveal disease: a longitudinal study of iridociliary cysts, pigmentary uveitis, and pigmentary/cystic glaucoma over a decade in western Canada. ( 26119416 )
2016
2
Cytokines: their role in uveal disease. ( 9349412 )
1997
3
A-mode echography in the diagnosis of uveal disease. ( 880517 )
1977
4
Methotrexate treatment of uveal disease. ( 5904740 )
1966
5
Retinal lesions associated with uveal disease. I. ( 13372709 )
1956
6
The influence of hypersensitivity on endogenous uveal disease. ( 20288588 )
1947
7
The influence of hypersensitivity on endogenous uveal disease. ( 20279194 )
1946
8
Concerning the Use of Diphtheria Antitoxin in Post-Operative Infections and Acute Uveal Disease. ( 16692610 )
1922

Variations for Uveal Diseases

Expression for Uveal Diseases

Search GEO for disease gene expression data for Uveal Diseases.

Pathways for Uveal Diseases

GO Terms for Uveal Diseases

Sources for Uveal Diseases

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....